Digirad Co. (NASDAQ:DRAD) insider Matthew G. Molchan acquired 25,000 shares of the firm’s stock in a transaction on Wednesday, February 28th. The shares were bought at an average cost of $2.14 per share, for a total transaction of $53,500.00. Following the completion of the acquisition, the insider now owns 77,819 shares of the company’s stock, valued at $166,532.66. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Digirad stock opened at $1.90 on Monday. The company has a current ratio of 1.51, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70. The stock has a market cap of $38.18, a price-to-earnings ratio of -1.07 and a beta of 1.89. Digirad Co. has a twelve month low of $1.80 and a twelve month high of $5.60.
Digirad (NASDAQ:DRAD) last posted its quarterly earnings data on Friday, February 23rd. The medical equipment provider reported ($0.14) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.05 by ($0.19). The company had revenue of $30.92 million for the quarter. Digirad had a negative net margin of 30.19% and a positive return on equity of 0.32%.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th were paid a $0.055 dividend. This represents a $0.22 annualized dividend and a dividend yield of 11.58%. The ex-dividend date of this dividend was Wednesday, February 14th. Digirad’s dividend payout ratio is currently -12.36%.
Separately, ValuEngine downgraded shares of Digirad from a “buy” rating to a “hold” rating in a report on Sunday, December 31st.
Several large investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. lifted its stake in shares of Digirad by 24.2% in the second quarter. Goldman Sachs Group Inc. now owns 42,810 shares of the medical equipment provider’s stock worth $173,000 after buying an additional 8,347 shares in the last quarter. New York State Common Retirement Fund lifted its stake in shares of Digirad by 22.0% in the third quarter. New York State Common Retirement Fund now owns 172,901 shares of the medical equipment provider’s stock worth $597,000 after buying an additional 31,200 shares in the last quarter. Macquarie Group Ltd. lifted its stake in shares of Digirad by 30.7% in the fourth quarter. Macquarie Group Ltd. now owns 139,088 shares of the medical equipment provider’s stock worth $358,000 after buying an additional 32,697 shares in the last quarter. Heartland Advisors Inc. lifted its stake in shares of Digirad by 10.0% in the fourth quarter. Heartland Advisors Inc. now owns 970,605 shares of the medical equipment provider’s stock worth $2,499,000 after buying an additional 88,134 shares in the last quarter. Finally, Ariel Investments LLC lifted its stake in shares of Digirad by 91.7% in the fourth quarter. Ariel Investments LLC now owns 1,222,819 shares of the medical equipment provider’s stock worth $3,149,000 after buying an additional 584,777 shares in the last quarter. 56.14% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: This report was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://ledgergazette.com/2018/03/19/digirad-co-drad-insider-matthew-g-molchan-acquires-25000-shares.html.
Digirad Company Profile
Digirad Corporation provides healthcare solutions. The Company’s segments include Diagnostic Services, Mobile Healthcare, Diagnostic Imaging and Medical Device Sales and Services. Through Diagnostic Services, the Company offers an imaging services program as an alternative to purchasing equipment or outsourcing the procedures to another physician or imaging center.
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.